Editorial 21

نویسندگان

چکیده

Editorial 21

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Editorial 21/1

Dear Readers of Electronic Markets, “We are happy, if we were able to spark or deepen your interest in electronic markets ...”. This was the message of the editorial of the first issue of Electronic Markets, back in September 1991 when “EM” started as a newsletter. Justin-time for its 20th anniversary the journal has been selected by Thomson Reuters for the Social Sciences Citation Index, the J...

متن کامل

01 - Nefrologia 21-2 - Editorial

Erythropoiesis Stimulating Agent (ESA) therapy has transformed the management of CKD anaemia over the last couple of decades. Not only is the treatment highly effective, but it is one of the safest therapies that nephrologists use. Adverse effects are uncommon, and apart from occasional exacerbation of hypertension (which is usually easily managed), the treatment is remarkably well tolerated. T...

متن کامل

EDITORIAL Rehabilitation for the 21 st Century

" You'd better go check this out. That aircar was flying erratically and it's been off the screen for 5 minutes now, " the shift commander said, looking my way. " But chief, there's been no signal from any emergency personal distress unit, " I said hopefully. It was late and my shift on the emergency medical response team had begun early that morning. " I just have a feeling we should check thi...

متن کامل

02 - Nefrologia 21-4 - Editorial non-oliguric

In the pre-RRT era, many patients with oliguric ARF died of hyperkalaemia or fluid overload. With the advent of RRT, it quickly became apparent that these complications could be averted or treated by the initiation of RRT1. However, just as in chronic renal failure, precise indications for initiation of RRT have never been established2. In the modern era, it is conventional to initiate RRT when...

متن کامل

03 - Nefrologia 21-4 - Editorial Therapeutic Advances

Polycystic Kidney Disease (PKD) is one of the most common hereditary diseases in humans, accounting for almost 5-10% of subjects on renal replacement therapies1. Although clinical symptoms occur most frequently in adult life, the hereditary nature of PKD has permitted the screening of first degree relatives and therefore to reach a diagnosis in early adulthood. That said, early diagnosis per se...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Communication papers

سال: 2021

ISSN: ['2014-6752']

DOI: https://doi.org/10.33115/udg_bib/cp.v10i21.22735